Hereditary Cancer in Clinical Practice (Sep 2021)
Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
- Krithika Murali,
- Tanya M. Dwarte,
- Mehrdad Nikfarjam,
- Katherine M. Tucker,
- Rhys B. Vaughan,
- Marios Efthymiou,
- Allison Collins,
- Allan D. Spigelman,
- Lucinda Salmon,
- Amber L. Johns,
- David B. Williams,
- Martin B. Delatycki,
- Thomas John,
- Alina Stoita
Affiliations
- Krithika Murali
- Department of Clinical Genetics, Austin Health
- Tanya M. Dwarte
- Australian Pancreatic Cancer Genome Initiative, Garvan Institute of Medical Research
- Mehrdad Nikfarjam
- Division of Surgery, Austin Health
- Katherine M. Tucker
- Hereditary Cancer Centre, Prince of Wales Hospital
- Rhys B. Vaughan
- Department of Gastroenterology, Austin Health
- Marios Efthymiou
- Department of Gastroenterology, Austin Health
- Allison Collins
- Clinical Trials Unit, Olivia Newton John Cancer and Wellness Centre, Austin Health
- Allan D. Spigelman
- University of New South Wales, St Vincent’s Clinical School and Prince of Wales Clinical School
- Lucinda Salmon
- Department of Clinical Genetics, Austin Health
- Amber L. Johns
- Australian Pancreatic Cancer Genome Initiative, Garvan Institute of Medical Research
- David B. Williams
- Department of Gastroenterology, St Vincent’s Hospital
- Martin B. Delatycki
- Department of Clinical Genetics, Austin Health
- Thomas John
- Peter MacCallum Cancer Centre
- Alina Stoita
- Department of Gastroenterology, St Vincent’s Hospital
- DOI
- https://doi.org/10.1186/s13053-021-00195-w
- Journal volume & issue
-
Vol. 19,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
